SEC Form 4 · accession 0001140361-16-067454
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zsolt Harsanyi
Director
Period of report
May 24, 2016
Accepted (ET)
May 26, 2016 · 9:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 24, 2016 | M | 7,200 | $16.13 | A | 41,685 | D | |
| Common StockF1,F2 | May 24, 2016 | S | 7,200 | $42.26 | D | 34,485 | D | |
| Common StockF3 | May 24, 2016 | M | 7,200 | $22.02 | A | 41,685 | D | |
| Common StockF3,F4 | May 24, 2016 | S | 7,200 | $42.26 | D | 34,485 | D | |
| Common StockF5 | May 24, 2016 | M | 2,400 | $14.66 | A | 36,885 | D | |
| Common StockF5,F6 | May 24, 2016 | S | 2,400 | $42.34 | D | 34,485 | D | |
| Common StockF7 | May 25, 2016 | M | 4,800 | $14.25 | A | 39,285 | D | |
| Common StockF7,F8 | May 25, 2016 | S | 4,800 | $42.41 | D | 34,485 | D | |
| Common StockF9 | May 25, 2016 | M | 6,267 | $20.44 | A | 40,752 | D | |
| Common StockF9,F10 | May 25, 2016 | S | 6,267 | $42.41 | D | 34,485 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF11 | $16.13 | May 24, 2016 | M | 7,200 | D | May 20, 2013 | May 20, 2020 | Common Stock | 7,200 | 0 | D |
| Stock OptionF11 | $22.02 | May 24, 2016 | M | 7,200 | D | May 19, 2014 | May 19, 2022 | Common Stock | 7,200 | 0 | D |
| Stock OptionF11 | $14.66 | May 24, 2016 | M | 2,400 | D | May 17, 2015 | May 17, 2019 | Common Stock | 2,400 | 0 | D |
| Stock OptionF11 | $14.25 | May 25, 2016 | M | 4,800 | D | May 23, 2016 | May 22, 2021 | Common Stock | 2,400 | 0 | D |
| Stock Option (Common Stock)F11 | $20.44 | May 25, 2016 | M | 6,267 | D | May 22, 2016 | May 22, 2022 | Common Stock | 6,267 | 3,133 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on May 20, 2010.
- F10The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.12 to $42.52, inclusive.
- F11All options vested in three equal installments on the anniversary date of the grant.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.10 to $42.37, inclusive.
- F3Consists of an option granted under the company's stock incentive plan on May 19, 2011.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.06 to $42.37, inclusive.
- F5Consists of an option granted under the company's stock incentive plan on May 17, 2012.
- F6The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $42.38, inclusive.
- F7Consists of an option granted under the company's stock incentive plan on May 23, 2013.
- F8The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.17 to $42.53, inclusive.
- F9Consists of an option granted under the company's stock incentive plan on May 22, 2014.